# Atara Biotherapeutics, Inc.: Form 8-K, filed Jan 8, 2024

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2024-01-08
- Accepted by EDGAR: Jan 8, 2024, 08:11 ET
- Period: 2024-01-08
- Accession: 0001193125-24-003945
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000119312524003945/d703405d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000119312524003945/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000119312524003945/d703405d8k.htm

Filed Jan 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-003945. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
